Zimmer Biomet (ZBH) PT Lowered to $91 at Bernstein SocGen Group
Bernstein SocGen Group analyst Lee Hambright lowered the price target on Zimmer Biomet (NYSE: ZBH) to $91.00 (from $99.00) while maintaining a Market Perform rating.
Bernstein SocGen Group analyst Lee Hambright lowered the price target on Zimmer Biomet (NYSE: ZBH) to $91.00 (from $99.00) while maintaining a Market Perform rating.